IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Pilot Study of Text Message Reminders to Improve HIV Medication Adherence in Botswana
This study has been completed.
Sponsor:
University of Pennsylvania
Information provided by (Responsible Party):
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01001741
First received: October 23, 2009
Last updated: September 16, 2015
Last verified: June 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
While medication adherence is critical to successful treatment of HIV, there are few studies of interventions demonstrating improvements in adherence. This may be a particular challenge in the developing world, which has a larger burden of HIV but fewer resources than industrialized countries. The investigators propose a randomized controlled trial of cellular phone text message reminders to improve medication adherence. Our pilot study will be set in a large HIV clinic in Gaborone, Botswana, where Penn researchers have collaborated on research projects in the past. The primary study outcome will be antiretroviral medication adherence.
| Condition | Intervention |
|---|---|
| HIV Infections | Other: Cell phone text message |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | A Pilot Study of Cellular Phone Text Message Reminders to Improve HIV Medication Adherence at Independence Surgery Clinic Gaborone, Botswana |
Resource links provided by NLM:
Further study details as provided by University of Pennsylvania:
Primary Outcome Measures:
- HIV medication adherence [ Time Frame: Monthly ]
| Enrollment: | 128 |
| Study Start Date: | June 2008 |
| Study Completion Date: | August 2009 |
| Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |
Intervention Details:
-
Other: Cell phone text message
We will use cellular text messages to remind patients of impending drug prescription refills and scheduled visits to their healthcare provider.
Eligibility| Ages Eligible for Study: | 21 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- HIV infected
- 21 years of age or older
Exclusion Criteria:
- Subjects who do not intend to have continuous follow-up care and monthly medication refills at Independence Surgery for at least the next six months
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01001741
Please refer to this study by its ClinicalTrials.gov identifier: NCT01001741
Locations
| Botswana | |
| Independence Surgery | |
| Gaborone, Botswana | |
Sponsors and Collaborators
University of Pennsylvania
Investigators
| Study Director: | Darren Linkin, MD | University of Pennsylvania |
| Principal Investigator: | Harvey Friedman, MD | University of Pennsylvania |
| Study Director: | James Thompson, MBA | Wharton Business School, UPenn |
| Study Director: | Andrew Steenhoff | University of Pennsylvania |
More Information
Publications:
| Responsible Party: | University of Pennsylvania |
| ClinicalTrials.gov Identifier: | NCT01001741 History of Changes |
| Other Study ID Numbers: |
805891 NIH: P30 AI 045008 |
| Study First Received: | October 23, 2009 |
| Last Updated: | September 16, 2015 |
Keywords provided by University of Pennsylvania:
|
HIV Antiretrovirals Adherence |
Text messaging Antiretroviral adherence Treatment experienced |
Additional relevant MeSH terms:
|
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |
ClinicalTrials.gov processed this record on June 23, 2017